• Angiotensin II in Vascular Remodeling: Protocols & Innovatio

  2026-06-22

  Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) is a cornerstone for dissecting hypertension, vascular smooth muscle cell hypertrophy, and cardiovascular remodeling mechanisms. This guide translates the latest reference findings and practical workflows, with stepwise protocols, troubleshooting, and advanced applications for maximizing research impact.

• NLRP3 Inflammasome-Mediated Astrocyte Shifts in Morphine Tol

  2026-06-22

  Yuan et al. (2024) delineate how NLRP3 inflammasome activation drives astrocyte phenotype changes underlying morphine tolerance. Their work demonstrates that selective inhibition of NLRP3 reverses neuroinflammatory markers and delays tolerance development, highlighting new mechanistic targets for inflammatory disease research.

• Mouse Tissue Lysis Kit (K1038): Workflow, Protocol, and QC G

  2026-06-21

  The Mouse Tissue Lysis Kit (K1038) streamlines preparation of mouse tissue lysates for direct use in genotyping assays, eliminating traditional extraction and purification. It is intended for research applications in molecular biology and not suitable for diagnostic or medical use.

• Advances in Silybin Chemistry: Structure, Isolation, and Der

  2026-06-20

  The landmark review by Křen et al. systematically dissects the chemical foundation, isolation, and derivatization of silybin, the principal flavonolignan of silymarin. This work establishes critical methodologies and structural insights that have shaped research into hepatoprotective, antioxidant, and metabolic enzyme-modulating agents for liver disease studies.

• Cy3 Rabbit Anti-Goat IgG (H+L) Antibody: Technical Use Guide

  2026-06-19

  The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody addresses the need for reliable, specific fluorescence-based detection of goat IgG in immunocytochemistry, IHC, flow cytometry, and ELISA. It is optimized for workflows requiring high sensitivity and low background. This reagent should not be used for detection of non-goat primaries or outside validated immunodetection applications.

• SU 5402 Applications: Optimizing RTK Inhibition in Cancer &

  2026-06-19

  SU 5402 unlocks precise receptor tyrosine kinase inhibition for both cancer biology and advanced neuron models, enabling reproducible cell cycle arrest and apoptosis studies. This guide delivers actionable workflows, troubleshooting advice, and insights from recent iPSC-neuron virology research for robust experimental design.

• Applied Use of Mianserin HCl: 5-HT2 Receptor Antagonist in R

  2026-06-18

  Mianserin HCl stands out as a robust 5-HT2 receptor antagonist, uniquely enabling both psychiatric disorder research and antipathogenic studies through its selective mechanism and cyclodextrin complexing. This article details advanced workflows, practical troubleshooting, and protocol enhancements for maximizing its experimental value.

• Clozapine in Schizophrenia Research: ERK1/2 Signaling and Be

  2026-06-18

  Explore the multifaceted role of Clozapine as an atypical antipsychotic medication in schizophrenia research. This article offers advanced insights into ERK1/2 signaling, receptor pharmacology, and how Clozapine's mechanisms contrast with emerging neuromodulatory approaches.

• AAL-993: Precision VEGF Receptor Inhibitor for Tumor Angioge

  2026-06-17

  AAL-993 stands out as a highly selective VEGF receptor inhibitor, enabling robust and reproducible tumor angiogenesis modeling. Its superior potency and workflow adaptability empower researchers to dissect anti-angiogenic mechanisms in both in vitro and in vivo settings.

• T-5224: C-Fos/AP-1 Inhibitor for Precision Inflammation Rese

  2026-06-17

  T-5224 sets a new standard in dissecting AP-1 mediated pathways, enabling precise experimental control over neuroinflammatory and arthritic models. Its specificity for c-Fos/c-Jun DNA binding opens advanced use-cases for targeted cytokine and MMP inhibition, with workflow-ready guidance for both in vitro and in vivo protocols.

• 5X Protein Loading Buffer (Reducing): Protocol and Workflow

  2026-06-16

  5X Protein Loading Buffer (Reducing) is formulated to ensure thorough denaturation and reduction of proteins for accurate, molecular weight-based separation in SDS-PAGE. It is recommended for workflows requiring reducing conditions and is not suitable for analyses that require native or non-reducing conditions.

• Liproxstatin-1 HCl in Ferroptosis Assays: Protocols & Soluti

  2026-06-16

  Liproxstatin-1 HCl enables precise inhibition of lipid peroxidation, empowering robust ferroptosis assays and acute injury models. This guide delivers actionable protocols, key troubleshooting insights, and translates new mitochondrial calcium signaling findings into practical workflow optimizations.

• SCUBE3 Antibody Targeting Suppresses Tumor Growth and Resist

  2026-06-15

  The reference study identifies secretory SCUBE3 as a key driver of tumor progression, therapy resistance, and immune evasion across multiple cancer types. By developing and applying a first-in-class neutralizing antibody against SCUBE3, the researchers demonstrate potent inhibition of oncogenic signaling and restoration of antitumor immunity, offering a promising pan-cancer therapeutic strategy.

• Z-YVAD-FMK: A Selective Caspase-1 Inhibitor for Cell Death S

  2026-06-15

  Z-YVAD-FMK enables researchers to dissect caspase-1-driven apoptosis and pyroptosis with unmatched specificity. This article delivers actionable protocols, advanced applications, and troubleshooting insights, translating recent bench research into optimized workflows for inflammation and cancer studies.

• Dihydrotestosterone (DHT): Applied Workflows in AR & EGFR Re

  2026-06-14

  Harness the power of Dihydrotestosterone (DHT) for advanced androgen receptor (AR) and EGFR pathway studies. This guide delivers actionable protocols, troubleshooting advice, and experimental insights, leveraging APExBIO's DHT for reproducibility in cancer and neurodegenerative disease models.

15785 records 1/1053 page Next 12345 下5页 Last page